A.RBC4.0×1012/L,Hb75g/L,MCV63fl,MCH22pg,MCHC0.25,網(wǎng)織紅細(xì)胞0.010
B.RBC2.3×1012/L,Hb85g/L,MCV94fl,MCH35pg,MCHC0.35,網(wǎng)織紅細(xì)胞0.015
C.RBC2.0×1012/L,Hb60g/L,MCV84fl,MCH30pg,MCHC0.33,網(wǎng)織紅細(xì)胞0.003
D.RBC4.5×1012/L,Hb115g/L,MCV83fl,MCH31pg,MCHC0.34,網(wǎng)織紅細(xì)胞0.015
E.RBC2.2×1012/L,Hb63g/L,MCV81fl,MCH32pg,MCHC0.33,網(wǎng)織紅細(xì)胞0.09
您可能感興趣的試卷
你可能感興趣的試題
A.RBC4.0×1012/L,Hb75g/L,MCV63fl,MCH22pg,MCHC0.25,網(wǎng)織紅細(xì)胞0.010
B.RBC2.3×1012/L,Hb85g/L,MCV94fl,MCH35pg,MCHC0.35,網(wǎng)織紅細(xì)胞0.015
C.RBC2.0×1012/L,Hb60g/L,MCV84fl,MCH30pg,MCHC0.33,網(wǎng)織紅細(xì)胞0.003
D.RBC4.5×1012/L,Hb115g/L,MCV83fl,MCH31pg,MCHC0.34,網(wǎng)織紅細(xì)胞0.015
E.RBC2.2×1012/L,Hb63g/L,MCV81fl,MCH32pg,MCHC0.33,網(wǎng)織紅細(xì)胞0.09
A.RBC4.0×1012/L,Hb75g/L,MCV63fl,MCH22pg,MCHC0.25,網(wǎng)織紅細(xì)胞0.010
B.RBC2.3×1012/L,Hb85g/L,MCV94fl,MCH35pg,MCHC0.35,網(wǎng)織紅細(xì)胞0.015
C.RBC2.0×1012/L,Hb60g/L,MCV84fl,MCH30pg,MCHC0.33,網(wǎng)織紅細(xì)胞0.003
D.RBC4.5×1012/L,Hb115g/L,MCV83fl,MCH31pg,MCHC0.34,網(wǎng)織紅細(xì)胞0.015
E.RBC2.2×1012/L,Hb63g/L,MCV81fl,MCH32pg,MCHC0.33,網(wǎng)織紅細(xì)胞0.09
A.血紅蛋白測(cè)定
B.血清鐵蛋白測(cè)定
C.紅細(xì)胞游離原卟啉測(cè)定
D.血清鐵測(cè)定
E.血清總鐵結(jié)合力
A.血紅蛋白測(cè)定
B.血清鐵蛋白測(cè)定
C.紅細(xì)胞游離原卟啉測(cè)定
D.血清鐵測(cè)定
E.血清總鐵結(jié)合力
A.紅細(xì)胞形態(tài)為小細(xì)胞
B.紅細(xì)胞形態(tài)為小細(xì)胞低色素
C.紅細(xì)胞形態(tài)為正細(xì)胞正色素
D.紅細(xì)胞形態(tài)為小細(xì)胞高色素
E.紅細(xì)胞形態(tài)為大細(xì)胞
最新試題
免疫抑制劑治療感染相關(guān)噬血細(xì)胞綜合征的主要原理是()
下列關(guān)于Burkitt淋巴瘤描述正確的是()
下列哪項(xiàng)檢查對(duì)霍奇金病具有確診意義()
下列有關(guān)蠶豆病的描述哪一項(xiàng)正確()
確診組織細(xì)胞壞死性淋巴結(jié)炎的診斷手段是()
下面哪一項(xiàng)符合急性ITP的檢查結(jié)果()
對(duì)兒童急性淋巴細(xì)胞白血病長(zhǎng)期無(wú)病生存影響最重要的藥物是()
下列有關(guān)朗格漢斯細(xì)胞組織細(xì)胞增生癥勒-雪病的描述正確的是()
口服鐵劑治療時(shí)采取下列哪一項(xiàng)措施能夠促進(jìn)鐵的吸收()
關(guān)于營(yíng)養(yǎng)性巨幼細(xì)胞貧血,下列哪項(xiàng)正確()